Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
23565 | 342 | 28.9 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
62 | 3 | CARDIAC & CARDIOVASCULAR SYSTEM//HEART FAILURE//PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 86105 |
2676 | 2 | LEVOSIMENDAN//CALCIUM SENSITIZER//MILRINONE | 3400 |
23565 | 1 | VESNARINONE//TSC 22//POSITIVE INOTROPIC ACTIVITY | 342 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | VESNARINONE | authKW | 3013314 | 13% | 75% | 45 |
2 | TSC 22 | authKW | 2244412 | 8% | 93% | 27 |
3 | POSITIVE INOTROPIC ACTIVITY | authKW | 1032113 | 5% | 68% | 17 |
4 | OPC 18790 | authKW | 657452 | 3% | 82% | 9 |
5 | BUNCHED | authKW | 285707 | 1% | 80% | 4 |
6 | 1 2 4TRIAZOLO3 4 APHTHALAZINE | authKW | 267852 | 1% | 100% | 3 |
7 | OPC 8212 | authKW | 267852 | 1% | 100% | 3 |
8 | 1 2 4TRIAZOLO4 3 AQUINOLINES | authKW | 238088 | 1% | 67% | 4 |
9 | TOBORINONE | authKW | 238088 | 1% | 67% | 4 |
10 | QUINOLINONE DERIVATIVE | authKW | 200888 | 1% | 75% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 1099 | 17% | 0% | 59 |
2 | Pharmacology & Pharmacy | 784 | 29% | 0% | 100 |
3 | Cardiac & Cardiovascular System | 293 | 13% | 0% | 43 |
4 | Oncology | 146 | 13% | 0% | 43 |
5 | Developmental Biology | 118 | 4% | 0% | 14 |
6 | Chemistry, Multidisciplinary | 94 | 13% | 0% | 46 |
7 | Chemistry, Organic | 80 | 8% | 0% | 29 |
8 | Cell Biology | 32 | 7% | 0% | 24 |
9 | Biochemistry & Molecular Biology | 28 | 12% | 0% | 42 |
10 | Peripheral Vascular Diseases | 18 | 3% | 0% | 10 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NAT OURCES FUNCT MOL CHANGBAI MT | 196407 | 3% | 20% | 11 |
2 | AFFILIATED MINIST EDUC | 136438 | 3% | 17% | 9 |
3 | AVD CLIN | 89284 | 0% | 100% | 1 |
4 | DKFZ ZMBH ALLIANCENETWORK AGING GERMAN CANC | 89284 | 0% | 100% | 1 |
5 | HEMATOPOIESIS PHYSIOL | 89284 | 0% | 100% | 1 |
6 | JOINT MOL METAB CONTROL MOL BIOL HEIDELBE | 89284 | 0% | 100% | 1 |
7 | JR GRP CELLULAR SENESCENCE | 89284 | 0% | 100% | 1 |
8 | MARYLAND OFF CLIN | 89284 | 0% | 100% | 1 |
9 | PASTEURSECT NEUROSCI | 89284 | 0% | 100% | 1 |
10 | STADT KRANKENHAUS FRIEDRICHSHAFEN | 89284 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 2911 | 4% | 0% | 12 |
2 | CARDIOVASCULAR DRUG REVIEWS | 1907 | 1% | 1% | 3 |
3 | CHEMICAL & PHARMACEUTICAL BULLETIN | 1146 | 4% | 0% | 15 |
4 | HELVETICA CHIMICA ACTA | 819 | 3% | 0% | 9 |
5 | JAPANESE JOURNAL OF PHARMACOLOGY | 724 | 2% | 0% | 6 |
6 | JAPANESE HEART JOURNAL | 668 | 1% | 0% | 4 |
7 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 507 | 2% | 0% | 8 |
8 | CHEMICAL BIOLOGY & DRUG DESIGN | 481 | 1% | 0% | 3 |
9 | CHINESE JOURNAL OF ORGANIC CHEMISTRY | 449 | 1% | 0% | 5 |
10 | CARDIOVASCULAR DRUGS AND THERAPY | 410 | 1% | 0% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VESNARINONE | 3013314 | 13% | 75% | 45 | Search VESNARINONE | Search VESNARINONE |
2 | TSC 22 | 2244412 | 8% | 93% | 27 | Search TSC+22 | Search TSC+22 |
3 | POSITIVE INOTROPIC ACTIVITY | 1032113 | 5% | 68% | 17 | Search POSITIVE+INOTROPIC+ACTIVITY | Search POSITIVE+INOTROPIC+ACTIVITY |
4 | OPC 18790 | 657452 | 3% | 82% | 9 | Search OPC+18790 | Search OPC+18790 |
5 | BUNCHED | 285707 | 1% | 80% | 4 | Search BUNCHED | Search BUNCHED |
6 | 1 2 4TRIAZOLO3 4 APHTHALAZINE | 267852 | 1% | 100% | 3 | Search 1+2+4TRIAZOLO3+4+APHTHALAZINE | Search 1+2+4TRIAZOLO3+4+APHTHALAZINE |
7 | OPC 8212 | 267852 | 1% | 100% | 3 | Search OPC+8212 | Search OPC+8212 |
8 | 1 2 4TRIAZOLO4 3 AQUINOLINES | 238088 | 1% | 67% | 4 | Search 1+2+4TRIAZOLO4+3+AQUINOLINES | Search 1+2+4TRIAZOLO4+3+AQUINOLINES |
9 | TOBORINONE | 238088 | 1% | 67% | 4 | Search TOBORINONE | Search TOBORINONE |
10 | QUINOLINONE DERIVATIVE | 200888 | 1% | 75% | 3 | Search QUINOLINONE+DERIVATIVE | Search QUINOLINONE+DERIVATIVE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KAWAMATA, H , ORNOTEHARA, F , NAKASHIRO, K , UCHIDA, D , HINO, S , FUJIMORI, T , (2003) VESNARINONE: A DIFFERENTIATION-INDUCING ANTI-CANCER DRUG.ANTI-CANCER DRUGS. VOL. 14. ISSUE 6. P. 391-395 | 44 | 88% | 3 |
2 | UCHIDA, D , KAWAMATA, H , OMOTEHARA, F , MIWA, Y , HORIUCHI, H , FURIHATA, T , TACHIBANA, M , FUJIMORI, T , (2016) OVEREXPRESSION OF TSC-22 (TRANSFORMING GROWTH FACTOR-BETA-STIMULATED CLONE-22) CAUSES MARKED OBESITY, SPLENIC ABNORMALITY AND B CELL LYMPHOMA IN TRANSGENIC MICE.ONCOTARGET. VOL. 7. ISSUE 12. P. 14310 -14323 | 32 | 84% | 0 |
3 | KAWAMATA, H , TACHIBANA, M , FUJIMORI, T , IMAI, Y , (2006) DIFFERENTIATION-INDUCING THERAPY FOR SOLID TUMORS.CURRENT PHARMACEUTICAL DESIGN. VOL. 12. ISSUE 3. P. 379-385 | 44 | 57% | 37 |
4 | CHEN, LC , CHEN, IL , HUANG, CC , LIAO, CH , CHEN, JY , WANG, TC , (2010) SYNTHESIS, ANTIPROLIFERATIVE, AND ANTIPLATELET ACTIVITIES OF OXIME-CONTAINING 3,4-DIHYDROQUINOLIN-2(1H)-ONE DERIVATIVES.JOURNAL OF THE CHINESE CHEMICAL SOCIETY. VOL. 57. ISSUE 6B. P. 1331-1340 | 20 | 80% | 2 |
5 | WU, Y , PIAO, HR , (2013) THE PROGRESS TOWARDS THE DEVELOPMENT OF DHQO DERIVATIVES AND RELATED ANALOGUES WITH INOTROPIC EFFECTS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 13. ISSUE 12. P. 1801 -1811 | 26 | 54% | 1 |
6 | CHEN, IL , CHANG, KM , MIAW, CL , LIAO, CH , CHEN, JJ , WANG, TC , (2007) SYNTHESIS, ANTIPROLIFERATIVE, AND ANTIPLATELET ACTIVITIES OF OXIME- AND AMIDE-CONTAINING QUINOLIN-2(1H)-ONE DERIVATIVES.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 15. ISSUE 20. P. 6527-6534 | 19 | 83% | 12 |
7 | HINO, S , KAWAMATA, H , OMOTEHARA, F , UCHIDA, D , MIWA, Y , BEGUM, NM , YOSHIDA, H , SATO, M , FUJIMORI, T , (2002) CYTOPLASMIC TSC-22 (TRANSFORMING GROWTH FACTOR-BETA-STIMULATED CLONE-22) MARKEDLY ENHANCES THE RADIATION SENSITIVITY OF SALIVARY GLAND CANCER CELLS.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 292. ISSUE 4. P. 957-963 | 18 | 90% | 16 |
8 | KAWAMATA, H , FUJIMORI, T , IMAI, Y , (2004) TSC-22 (TGF-BETA STIMULATED CLONE-22): A NOVEL MOLECULAR TARGET FOR DIFFERENTIATION-INDUCING THERAPY IN SALIVARY GLAND CANCER.CURRENT CANCER DRUG TARGETS. VOL. 4. ISSUE 6. P. 521-529 | 23 | 64% | 15 |
9 | WANG, TC , ZHAO, YL , KUO, DH , (2001) SYNTHESIS AND VASORELAXING EVALUATION OF ALPHA-METHYLIDENE-GAMMA-BUTYROLACTONE BEARING QUINOLIN-2(1H)-ONE AND 3,4-DIHYDROQUINOLIN-2(1H)-ONE DERIVATIVES.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 36. ISSUE 11-12. P. 909-914 | 20 | 80% | 7 |
10 | HINO, S , KAWAMATA, H , OMOTEHARA, F , UCHIDA, D , BEGUM, NM , YOSHIDA, H , SATO, M , FUJIMORI, T , (2002) LEUCINE ZIPPER STRUCTURE OF TSC-22 (TGF-BETA STIMULATED CLONE-22) MARKEDLY INHIBITS THE ANCHORAGE-INDEPENDENT GROWTH OF SALIVARY GLAND CANCER CELLS.ONCOLOGY REPORTS. VOL. 9. ISSUE 2. P. 371-374 | 17 | 89% | 7 |
Classes with closest relation at Level 1 |